DataMEDS AI is a Health IT company focused on the vertical integration of technology, pharmacy, pharmaceutical-adjacent, and telemedicine business units.
Datameds Ai stock last closed at $0.89, up 4.82% from the previous day, and has decreased 98.73% in one year. It has underperformed other stocks in the Pharmaceutical Retailers industry by 0.02 percentage points. Datameds Ai stock is currently +8.38% from its 52-week low of $0.82, and -98.89% from its 52-week high of $80.46.
As of Sep 10, 2026, there are 1.6M shares of MEDS outstanding. The market capitalization of MEDS is $1.43M. In the last 24 hours, 75,000 MEDS shares were traded.
You need an online brokerage account in order to access the NASDAQ market and buy MEDS stock.
Based on our research, eToro is the best brokerage. Here's why:
Get $10 towards your share purchase by creating an account with eToro now. This offer is only for US users.
Open eToro AccountNow that you've chosen your brokerage, you need to fill out some personal details so you can invest in MEDS stock today.
Now that you have filled out your info on the best stock app to use, your next step is to transfer the money for your investment:
Watch the walkthrough below to see the process of depositing money into your investment account.
After you have chosen the best place to buy Datameds Ai stock, it's absolutely critical to evaluate their stock prior to buying, so you actually comprehend the risk and upside.
WallStreetZen was built to help average investors do more in-depth fundamental analysis in minutes instead of hours.
You can view all of the due diligence checks on MEDS's stock page.
Analysts use a variety of different financial metrics, analyses, models, and charts to gauge MEDS's fair value.
You can access additional valuation analysis on MEDS's stock here.
You can dig deeper into what analysts are projecting on the Datameds Ai stock forecast page.
Last year, MEDS revenue was $8.02M. During the last 2 year, MEDS's revenue has gone up by -32.35% per year. This was slower than the Pharmaceutical Retailers industry average of 23.18%.
Learn more about MEDS's earnings and revenue performance here.
Over the last year, executives and large shareholders at MEDS have bought more shares than they have sold.
Surendra K. Ajjarapu, Director of MEDS, was the latest MEDS insider to buy. They bought $500.00 worth of MEDS shares on Jun 22, 2026.
Learn more about who owns MEDS shares here.
No, Datameds Ai doesn't provide an income stream by paying out dividends.
One of the primary reasons eToro is our highest-rated brokerage is because of its social trading community.
Click below to see what other investors have to say.
You have two main types of orders:
Press the Open button and your broker will execute your order.
If you require additional assistance buying stocks on eToro, click the how to video below:
Now that you own some MEDS stock, you'll want to keep up with your shares.
Start a watchlist to get the latest updates about your MEDS stock.
To summarize, here are the 6 steps to buy stock in Datameds Ai:
If you are looking for a place to buy stocks, eToro is our recommended venue.
Get Started with eToro TodayIf you would like to get notifications regarding your new investment in Datameds Ai, create a watchlist on WallStreetZen today.